The Expression of Vitamin D Receptor on Peripheral Blood Mononuclear Cells in Patients with Psoriasis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910677 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Azin Jasmin Zanghaneh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, Västmanlands Sjukhus Västerås, 721 89 Västerås, Sweden. Hauptthemen laut MEDLINE: Psoriasis, Receptors, Calcitriol, Leukocytes, Mononuclear, Etanercept. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer, Hudfonden—Edward Welanders stiftelse, The Center for Clinical Research Dalarna, Uppsala University.
Abstract (Originalsprache)
Vitamin D plays an important role in psoriasis, but its involvement in pathogenesis remains unclear. This study aimed to evaluate vitamin D receptor (VDR) expression on peripheral blood mononuclear cells (PBMCs) in patients with psoriasis and healthy controls and to study the effects of the Etanercept treatment on VDR expression on PBMCs in patients with psoriasis. Twenty patients with moderate to severe psoriasis received treatment with Etanercept for 24 weeks. The age- and sex-matched controls did not receive any intervention. VDR expression on CD3+ lymphocytes and CD14+ monocytes, and serum levels of total and free 25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxy vitamin D (1,25(OH)2D) were analyzed at baseline, after 10–12 weeks, and after 24 weeks in both groups. VDR expression was analyzed using flow cytometry. We observed higher expression of the VDR on CD14+ monocytes in psoriasis patients compared to healthy controls at baseline. This difference was no longer significant after 24 weeks of the Etanercept treatment. The patients with psoriasis improved clinically. However, VDR expression was unaltered during the Etanercept treatment, and there was no correlation between VDR expression and disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Venereology, Västmanlands Sjukhus Västerås, 721 89 Västerås, Sweden.
- Department of Dermatology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 413 45 Gothenburg, Sweden.
- Center for Clinical Research, Uppsala University, 791 82 Falun, Sweden.
- Department of Dermatology and Venereology, Sahlgrenska University Hospital, Region Västra Götaland, 413 45 Gothenburg, Sweden.
- Accident and Emergency Department, Northern Älvsborg County Hospital, 461 73 Trollhättan, Sweden.
- Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Region Västra Götaland, 413 45 Gothenburg, Sweden.
ORCID-Profile: Andrea Elmelid, Martin Gillstedt
Förderung
- Pfizer, Hudfonden—Edward Welanders stiftelse
- The Center for Clinical Research Dalarna, Uppsala University
Zitieren
APA
Zanghaneh, A. J., Elmelid, A., Gillstedt, M., Ahmic, O., Andersson, B., & Osmancevic, A. (2024). The Expression of Vitamin D Receptor on Peripheral Blood Mononuclear Cells in Patients with Psoriasis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910677
Vancouver
Zanghaneh AJ, Elmelid A, Gillstedt M, Ahmic O, Andersson B, Osmancevic A. The Expression of Vitamin D Receptor on Peripheral Blood Mononuclear Cells in Patients with Psoriasis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910677
BibTeX
@article{Zanghaneh2024,
author = {Zanghaneh, Azin Jasmin and Elmelid, Andrea and Gillstedt, Martin and Ahmic, Omar and Andersson, Bengt and Osmancevic, Amra},
title = {The Expression of Vitamin D Receptor on Peripheral Blood Mononuclear Cells in Patients with Psoriasis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910677}
}
EUVIMED